Hypothyroidism

Hypothyroidism is a condition in which the thyroid gland is underactive, resulting in a deficiency of the thyroid hormones triiodothyronine (T₃) and thyroxine (T₄). Rarely, hormone production remains sufficient, but thyroid hormones may have insufficient peripheral effects. Hypothyroidism may be congenital or acquired. Congenital hypothyroidism is usually caused by thyroid dysplasia or aplasia. The most common cause of acquired hypothyroidism in both adults and children is Hashimoto thyroiditis; other causes include iatrogenic harm. The pathophysiology of hypothyroidism is characterized mainly by a reduction of the basal metabolic rate and generalized myxedema. Clinical features include fatigue, cold intolerance, dry skin, and constipation. More severe manifestations include myxedematous heart disease and myxedema coma, which may be fatal if untreated. In adults, diagnosis is established based on serum thyroid-stimulating hormone (TSH) and free T₄ levels (FT₄). Hypothyroidism in children may be acquired or congenital. Congenital hypothyroidism is usually detected during neonatal screening, but it may also manifest with distinct features (e.g., macroglossia, large posterior fontanelle, umbilical hernia, prolonged jaundice). If untreated, congenital hypothyroidism can lead to severe developmental delay.

Prevalence: more common in women

• Women: up to 12:1,000
• Men: up to 4:1,000 [1]

Epidemiological data refers to the US, unless otherwise specified.

• Primary hypothyroidism: insufficient thyroid hormone production
  • Hashimoto thyroiditis
    • The most common cause of hypothyroidism in iodine-sufficient regions [2]
    • Associated with HLA-DR3 and other autoimmune diseases (e.g., vitiligo, pernicious anemia, type 1 diabetes, and systemic lupus erythematosus)
  • Postpartum thyroiditis (subacute lymphocytic thyroiditis) [2]
  • De Quervain thyroiditis (subacute granulomatous thyroiditis): often subsequent to a flu-like illness [2]
  • Iatrogenic: e.g., post thyroidectomy, radioiodine therapy, antithyroid medication (e.g., amiodarone, lithium)
  • Nutritional (insufficient intake of iodine): most common cause of hypothyroidism worldwide, particularly in iodine-deficient regions
  • Riedel thyroiditis: occurs in IgG₄-related systemic disease
  • Wolff-Chaikoff effect
  • Thyroid dysplasia: a disorder of embryologic development characterized by abnormal development and/or location of thyroid tissue (e.g., lingual thyroid)
• Secondary hypothyroidism: pituitary disorders (e.g., pituitary adenoma) → TSH deficiency
• Tertiary hypothyroidism: hypothalamic disorders → TRH deficiency

Hypothalamic-pituitary-thyroid axis [8]

The hypothalamus, anterior pituitary gland, and thyroid gland, together with their respective hormones, comprise a self-regulatory circuit referred to as the “Hypothalamic-pituitary-thyroid axis.”

• Primary hypothyroidism: peripheral (thyroid) disorders → T₃/T₄ are not produced (↓ levels) → compensatory ↑ TSH
• Secondary hypothyroidism: pituitary disorders → ↓ TSH levels → ↓ T₃/T₄ levels
• Tertiary hypothyroidism: hypothalamic disorders → ↓ TRH levels → ↓ TSH levels → ↓ T₃/T₄ levels

Effects of hypothyroidism [8][9]

• Generalized decrease in the basal metabolic rate → decreased oxygen and substrate consumption, leading to:
  • CNS: apathy, slowed cognition
  • Skin and appendages: skin dryness, alopecia
  • Lipid profile: ↑ low-density lipoproteins, ↑ triglycerides
  • Cold intolerance
• Decreased sympathetic activity leads to:
  • Decreased sweating
  • Cold skin (due to decreased blood flow)
  • Constipation (due to decreased gastrointestinal motility)
  • Bradycardia
• Decreased transcription of sarcolemmal genes (e.g., calcium ATPases) → decreased cardiac output, myopathy
• Hyperprolactinemia: ↑ prolactin production is stimulated by TRH → suppression of LH, FSH, GnRH, and testosterone and stimulation of breast tissue growth
• Myxedema: due to accumulation of glycosaminoglycans and hyaluronic acid within the reticular layer of the dermis
  • Complex protein mucopolysaccharides bind water → nonpitting edema
  • Initially, edema is pretibial, but as the condition progresses it can generalize, resulting in a range of symptoms (see “Clinical features” below).

• Symptoms related to decreased metabolic rate
  • Fatigue, decreased physical activity
  • Cold intolerance
  • Decreased sweating
  • Hair loss (Queen Anne sign), brittle nails, and cold, dry skin
  • Weight gain (despite poor appetite)
  • Constipation
  • Bradycardia
  • Hypothyroid myopathy, myalgia, stiffness, cramps
  • Woltman sign: a delayed relaxation of the deep tendon reflexes, which is commonly seen in patients with hypothyroidism, but may also be associated with advanced age, pregnancy, and diabetes mellitus.
  • Entrapment syndromes (e.g., carpal tunnel syndrome)
• Symptoms related to generalized myxedema
  • Doughy skin texture, puffy appearance
  • Myxedematous heart disease (dilated cardiomyopathy, bradycardia, dyspnea)
  • Hoarse voice, difficulty articulating words
  • Pretibial and periorbital edema, generalized nonpitting edema
  • Myxedema coma (see “Complications” below)
• Symptoms of hyperprolactinemia
  • Abnormal menstrual cycle; (esp. secondary amenorrhea; or menorrhagia)
  • Galactorrhea
  • Decreased libido, erectile dysfunction, delayed ejaculation, and infertility in men
• Further symptoms
  • Impaired cognition; (concentration, memory), somnolence, depression
  • Hypertension [10]
  • Goiter (in Hashimoto thyroiditis) or atrophic thyroid (in atrophic thyroiditis)

Older patients may not have typical symptoms of hypothyroidism. Instead, they may appear to have dementia or depression.

• Epidemiology
  • Occurs in 30–80% of individuals with hypothyroidism [11]
  • Most common in patients with Hashimoto thyroiditis [12]
    • ♂ = ♀
    • Age of onset: < 40 years
• Clinical features [12]
  • Slowly progressive proximal muscle weakness
  • Myalgia, muscle cramps, increased muscle tone
  • Myoedema (highly specific sign): localized painless muscle contraction induced by light muscle percussion or pressure that manifests with palpable muscle swelling.
  • Exercise intolerance (e.g., exertional pain)
  • Sensorimotor polyneuropathy
  • Slow DTRs and movement
  • Dupuytren contracture, trigger digit, carpal tunnel syndrome
  • Rare: rhabdomyolysis, compartment syndrome, Hoffmann syndrome, Kocher-Debre-Semelaigne syndrome
• Diagnosis [12]
  • ↑ Creatine kinase: 10–100× ULN
  • LDH: may be elevated
  • Thyroid autoantibodies: TgAB > TPOAb [13]
  • Electromyography: may show EMG findings of myopathy (nonspecific finding)
  • Muscle biopsy: indicated for the differential diagnosis of myopathy, usually normal
• Treatment [12]
  • Thyroid hormone replacement (see “Treatment of hypothyroidism”)
  • Most patients recover within months of starting levothyroxine replacement. [14]

Hypothyroid myopathy is a clinical feature of hypothyroidism. Perform a diagnostic workup for hypothyroidism in undiagnosed patients with persistently elevated muscle enzymes (e.g., creatine kinase, LDH).

Approach [15][16]

• Initial evaluation: thyroid function tests (TFTs)
  • Obtain TSH level for all patients: ↑ TSH with classic clinical features is typically diagnostic for primary hypothyroidism.
  • Abnormal TSH: Order FT₄.
• Further investigations: may be indicated to evaluate underlying etiology based on clinical suspicion (See also “Overview of common causes of primary hypothyroidism.”)
  • Thyroid antibody testing: Consider if autoimmune thyroiditis is suspected (not routinely indicated). [15]
  • Imaging: Consider if structural pathology (e.g., thyroid nodules, goiters, malignancy) is suspected. [17][18]

Normal TSH levels generally rule out primary hypothyroidism and hyperthyroidism and are therefore the decisive parameter in screening for both conditions. [19]

Laboratory studies

Thyroid function tests [15][16]

• TSH
  • Best initial screening test; also used to diagnose and monitor primary hypothyroidism
  • Reference ranges vary between laboratories and differ in pregnancy and with increasing age. [15]
• FT₄
  • Confirmatory test for primary hypothyroidism if TSH is elevated
  • Primary test in suspected secondary or tertiary hypothyroidism and following treatment for hyperthyroidism
• Free or total T₃: may be measured alongside FT₄, but not used for the diagnosis of hypothyroidism

Avoid routine TSH screening in acutely ill patients unless a thyroid disturbance is the suspected cause (e.g., myxedema coma), since other non-thyroid illnesses can interfere with serum TSH and results may be unreliable. [15]

TSH can be abnormal in both hyperthyroidism and hypothyroidism. Peripheral hormones (FT₄ and FT₃) are elevated in hyperthyroidism as opposed to hypothyroidism, in which levels are reduced. [16]

Serum thyroid antibody testing [15][22]

Serum thyroid antibody testing can confirm suspected autoimmune thyroid disease. Thyroid peroxidase antibody measurements may also be considered in patients with subclinical hypothyroidism or recurring miscarriages.

• Thyroglobulin antibodies (TgAb) and thyroid peroxidase antibodies (TPOAb): detectable in the majority of patients with autoimmune hypothyroidism
• TSH receptor antibodies (TRAbs): detectable in up to 20% of cases of autoimmune hypothyroidism [23]

Associated laboratory findings [16]

Other routine blood tests are not required for the diagnosis but may show characteristic changes.

• CBC: mild anemia
• BMP: hyponatremia (in acute hypothyroidism) , hypoglycemia (rare) [24][25]
• Lipid profile: hypercholesterolemia (increased LDL), hyperlipidemia
• Creatine kinase: increased in hypothyroid myopathy [26]

Imaging [18]

Imaging has no role in the primary evaluation of hypothyroidism but may be indicated if structural abnormalities are present or suspected.

• Thyroid ultrasound [17]
  • Useful for the assessment of thyroid vascularity, goiters, and thyroid nodules
  • Possible findings in hypothyroidism include signs of thyroiditis.
• Nuclear medicine thyroid scan [27]
  • May be indicated in the workup of thyroid nodules and goiters
  • In hypothyroidism, radiotracer activity is decreased.
• MRI brain (including pituitary gland): for suspected central hypothyroidism[28][29]

Nonthyroidal illness syndrome (NTIS) [21][30]

• Description
  • A change in thyroid hormone levels (typically decreased) that occurs in severe illness or severe physical stress
  • Common in intensive care patients and associated with morbidity and mortality
  • Also known as euthyroid sick syndrome (ESS)
• Pathophysiology: multifactorial and not fully understood [31]
  • Thyroid gland function typically remains normal.
  • Cytokines (e.g., interleukin 6) are thought to cause various changes in levels of circulating TSH and thyroid hormones.
  • Altered deiodinase enzyme activity leads to:
    • ↓ Conversion of T₄ to T₃
    • ↑ Conversion of T₄ to reverse T₃ (rT₃) by thyroxine 5-monodeiodinase
  • Various factors, e.g., protein loss due to nephrotic syndrome, may also lead to decreased levels of thyroid-binding globulin.
• Clinical features
  • Signs and symptoms of the underlying illness
  • Typically no classic symptoms of hyper- or hypothyroidism
• Diagnostics
  • NTIS is typically diagnosed incidentally following TFT screening done in critically ill patients to rule out thyrotoxicosis or hypothyroidism as the underlying cause, e.g., patients with unexplained tachyarrhythmias or heart failure, suspected myxedema coma, or a strong family history of thyroid disease.
  • TSH is typically normal in both low T₃ syndrome and low T₃ low T₄ syndrome.
    • Low T₃ syndrome: decrease in both total and FT₃ levels, normal FT₄ and TSH, and normal or increased rT₃
    • Low T₃ low T₄ syndrome: FT₄ levels may be low in prolonged courses of illness, indicating a poor prognosis.
  • Rarely, TSH may also be slightly low, but not enough to explain the low FT₃ and/or FT₄.
  • Consult endocrinology as the interpretation of TFTs in critically ill patients is complex and can be misleading.
• Treatment
  • Continued treatment of underlying illness
  • Thyroid hormone replacement is usually not recommended. [32]

Suspect NTIS in critically-ill patients who have a combination of the following: ↓ FT_3, normal or ↓ FT₄, normal or ↓ TSH, and absent typical clinical features of hypothyroidism. [21]

Other differential diagnoses [33]

The following conditions can mimic one or more manifestations of hypothyroidism:

• Adrenal insufficiency
• Hypopituitarism (can also be a cause of central hypothyroidism)
• CHF and other causes of pulmonary edema
• Other causes of shock
• Sepsis and other systemic infections
• Depression
• Major neurocognitive disorders
• Encephalopathy
• Environmental hypothermia
• Other differential diagnoses of constipation

The differential diagnoses listed here are not exhaustive.

General principles [15][20][32]

• Hypothyroidism is treated with lifelong hormone substitution.
  • Levothyroxine: synthetic form of T₄
    • First-line choice for the treatment of hypothyroidism
    • Peripherally converted to T₃ (biologically active metabolite) and rT₃ (biologically inactive metabolite)
  • Liothyronine: synthetic form of T₃
    • Part of the treatment for myxedema coma
    • Not recommended as monotherapy or in combination with levothyroxine for the long-term treatment of hypothyroidism [15][34][35]
• Starting dose and monitoring requirements vary depending on factors such as age and comorbidities.
• Reassess treatment response regularly to avoid undertreatment and overtreatment.

Indications for treatment [15][32]

• Overt hypothyroidism: Initiate treatment.
• Subclinical hypothyroidism: Treat select patients. [15][34]
  • Repeat TSH measurement after 1–3 months to confirm the diagnosis. [36]
  • Consider treatment in the following cases:
    • TSH ≥ 10 mIU/L
    • TSH < 10 mIU/L in addition to one of the following: positive TPOAb, cardiovascular risk factors, planned or current pregnancy

Ensure follow-up is in place for patients with subclinical hypothyroidism if treatment is not initiated.

Levothyroxine replacement [15][32]

• In primary hypothyroidism, levothyroxine is gradually titrated according to serial TSH measurements targeting a normal level; for example:
  • ↑ TSH (suggests ↓ T₄ activity): typically requires a dose increase
  • ↓ TSH (suggests ↑ T₄ activity): typically requires a dose decrease
• In secondary hypothyroidism, dosage is titrated according to FT₄ levels.

Titrate thyroid hormone substitution carefully for individuals with preexisting coronary artery disease. [32]

In patients with hypothyroidism who are pregnant, the levothyroxine dose must be increased in line with increased demand. Hypothyroidism adversely affects the development of the fetal nervous system. [16]

Long-term therapy considerations [15][32][39]

• Side effects: Overtreatment can lead to symptoms of thyrotoxicosis.
  • Sweating, heat intolerance, tremors
  • Tachycardia; , palpitations, arrhythmias
  • Weight loss, osteoporosis
  • See also “Exogenous thyrotoxicosis.”
• Drug interactions
  • Drugs that reduce levothyroxine absorption include PPIs, calcium salts, ferrous sulfate, and bile acid sequestrants.
  • Treatment with estrogens may necessitate a dose increase.
  • Treatment with androgens may necessitate a dose reduction.
  • Glucocorticoids interfere with thyroid hormone metabolism and the dose of levothyroxine may need to be reduced.
• Reasons for treatment failure
  • Nonadherence
  • Malabsorption due to gastrointestinal conditions (e.g., gastritis, celiac disease)

Some individuals may misuse synthetic thyroid hormones for weight loss. [40]

Myxedema coma [41][42]

• Definition: : extremely rare, potentially life-threatening decompensation of preexisting thyroid hormone deficiency
• Etiology
  • Triggers include infections, severe illness or trauma, and certain drugs.
  • Prior discontinuation of thyroid supplements is a frequent contributing factor in patients with known hypothyroidism.
• Clinical presentation
  • Cardinal symptoms: impaired mental status; , hypothermia; , and myxedema
  • Hypoventilation with hypercapnia and hypoxemia
  • Hypotension (possibly shock) and bradycardia
• Diagnosis [43]
  • Laboratory studies
    • TFTs: ↑ TSH and ↓ T₄ and T₃
    • BMP: hypoglycemia and hyponatremia [24]
    • ↓ Cortisol in patients with concomitant adrenal insufficiency
    • Other possible findings: ↑ CK and LDH, abnormal clotting
  • ECG: low-voltage QRS complexes, nonspecific T-wave changes [41]
  • CSF analysis: slightly ↑ CSF protein [42]
• Treatment [32][33][41]
  • Immediate measures: airway management and fluid resuscitation (See “ABCDE approach.”)
  • Intravenous hormone substitution: levothyroxine PLUS liothyronine PLUS hydrocortisone [32]
  • Supportive treatment: passive rewarming, ventilatory support as indicated, management of precipitating factors, treatment of hypoglycemia
• Disposition: Admission to critical care is typically warranted for ventilatory support, invasive monitoring, and management of electrolytes and fluids. [33]
• Prognosis: Even with treatment, mortality rates of up to 60% have been described. [41]

Remember to evaluate precipitating factors, e.g., screening for infectious causes, or obtaining cardiac enzymes and an ECG to exclude myocardial infarction. [41]

Suspect myxedema coma in patients with typical symptoms and a history of hypothyroidism, and initiate treatment immediately without waiting for laboratory results! [41]

Further complications

• Primary thyroid lymphoma
  • Hashimoto thyroiditis is the most common cause of hypothyroidism and the only known risk factor for primary thyroid lymphoma. [44]
  • Almost all primary thyroid lymphomas are non-Hodgkin large B-cell lymphomas.
• Increased cardiovascular risk
• Carpal tunnel syndrome [45]

We list the most important complications. The selection is not exhaustive.

• Perform ABCDE survey.
• Secure airway and begin ventilatory support if there is respiratory failure.
• Establish IV access and send blood samples for thyroid function tests, cortisol, BMP, CK, LDH, and coagulation panel.
• Start fluid resuscitation and vasopressors as needed.
• Begin continuous cardiac and respiratory monitoring and consider invasive BP monitoring.
• Check core temperature and consider passive rewarming.
• Identify and treat hypoglycemia.
• Urgently consult endocrinology and critical care for admission.
• Administer IV hydrocortisone together with or prior to thyroid hormone replacement and continue until concomitant adrenal insufficiency is ruled out. [32]
• Start IV levothyroxine and IV liothyronine.
• Identify and treat precipitating factors.
• Admit to ICU.

Hypothyroidism in children may be acquired or congenital. Tailor diagnosis and management approaches accordingly.

Epidemiology [5]

• US: affects ∼ 1:2300 newborns
• Worldwide: affects up to 1:2000 newborns

Etiology [6][46]

Permanent congenital hypothyroidism

• Primary congenital hypothyroidism: defects in the thyroid gland or thyroid hormone synthesis
  • Thyroid dysgenesis (most common)
    • Thyroid hypoplasia, dysplasia, or ectopy
    • Thyroid aplasia (athyroidism)
  • Hereditary dyshormonogenetic goiter: Defects in thyroid hormone synthesis (most commonly in thyroid peroxidase) lead to thyroid hyperplasia and goiter. [29]
• Central congenital hypothyroidism: rare; usually caused by pituitary disease [29]

Transient congenital hypothyroidism [47]

• Transplacental transmission of maternal antithyroid antibodies
• Fetal iodine deficiency syndrome: congenital hypothyroidism caused by iodine deficiency in utero (rare in iodine-sufficient areas) [47]

Congenital hypothyroidism may occur as part of another condition or genetic syndrome (e.g., Down syndrome). [6]

Clinical features of congenital hypothyroidism [6][29]

• Onset
  • Usually few or no features are present at birth, as maternal T₄ can cross the placenta. [46]
  • Features develop over weeks to months if hypothyroidism is untreated.
• General features [6][29][48]
  • Signs and symptoms of hypothyroidism, e.g.:
    • Hypothermia
    • Bradycardia
    • Constipation
  • Growth faltering (length affected more than weight) [49]
• Neonatal features
  • Umbilical hernia
  • Prolonged neonatal jaundice
  • Hypotonia
  • Decreased activity and poor feeding
  • Hoarse cry
  • Coarse facial features, macroglossia
  • Large posterior fontanelle
  • Mottled skin
  • Abdominal distension [50]
  • Associated congenital anomalies (e.g. cardiac, renal, gastrointestinal, and skeletal anomalies) [29]
• Features of severe untreated congenital hypothyroidism [6]
  • Intellectual disability
  • Short stature
  • Hearing loss

Most children with congenital hypothyroidism are asymptomatic at birth because maternal thyroid hormone crosses the placenta. Newborn screening is essential to allow early treatment and prevent irreversible intellectual disability. [6][29]

The 7 Ps of congenital hypothyroidism are Pot-bellied, Pale, Puffy-faced, Protruding umbilicus, Protuberant tongue, Poor brain development, and Prolonged neonatal jaundice.

Newborn screening [6][51]

• Indication: all infants [6]
• Methods [6]
  • TSH and/or T₄ measurements [6]
  • Heel-stick blood specimen between 24 hours and 1 week of life (preferably between 48 and 72 hours)
• Interpretation
  • Increased TSH levels and/or low T₄
    • Strongly suggest congenital hypothyroidism.
    • Confirm diagnosis with thyroid function tests (see "Initial management").
  • Normal TSH and T₄ [6]
    • Screen for high-risk features.
    • Infants with high-risk features: Repeat screening for hypothyroidism at 2–4 weeks of age. [6]

Congenital hypothyroidism is among the conditions mandated for newborn screening under federal law. [52]

Initial management [6]

The following outlines management of congenital hypothyrodism picked up on neonatal screening, however, a similar approach should be taken for children with normal neonatal screening or absent neonatal screening who later present with clinical features of hypothyroidism. [6]

Approach

• Consult with pediatric endocrinology to guide diagnosis and management.
• Determine if immediate treatment is required before performing confirmatory tests. [6][51]
  • TSH screening result > 40 mIU/L: Start levothyroxine while awaiting confirmatory results.
  • TSH screening result ≤ 40 mIU/L: Review full TFTs before initiating treatment.
• Obtain thyroid function tests (ideally within 24 hours) and begin management based on results. [6][51]
  • Start levothyroxine if the patient has:
    • Overt hypothyroidism
    • Normal free T₄ but TSH > 20 mIU/L
    • Low or normal TSH and low T₄ (suspected central hypothyroidism)
  • If the patient has a normal free T₄ but elevated TSH of ≤ 20 mIU/L:
    • Monitor thyroid function every 1–2 weeks.
    • Begin levothyroxine if TSH remains > 10 mIU/L after 4 weeks of age. [6][53]
• Consider imaging and additional diagnostic studies.
• Consider a formal hearing evaluation if there is concern about hearing [6]

Levothyroxine [6]

• Initiate oral levothyroxine as soon as possible after diagnosis.
• Titrate the dose in consultation with endocrinology with the aim of normalizing: [6][29]
  • T₄ levels within 2 weeks
  • TSH within 4 weeks
• Lifelong hormone replacement is necessary for children with permanent congenital hypothyroidism.

Adequate dosing and prompt initiation of levothyroxine treatment helps preserve normal long-term neurocognitive function. [6][29]

Imaging [6][53]

• Thyroid imaging is only performed if results will change management.
• Can identify thyroid dysgenesis
• Modalities include:
  • Ultrasound: no radiation, but sensitivity is lower than scintigraphy
  • Scintigraphy: radiation exposure; must be performed when TSH is elevated

Additional diagnostics based on risk factors [6][46]

• History of maternal autoimmune disease [6]
  • Obtain TSH receptor antibody (TRAb) levels
  • If levels are elevated, continue levothyroxine but advise caregivers that the hypothyroidism is likely transient.
• Features of central hypothyroidism (e.g., low or normal TSH and low T₄)
  • Obtain thyroxine-binding globulin concentration if TSH is low and free T₄ is normal. [6]
  • Assess for additional pituitary hormone deficits. [29]
  • Consider:
    • CNS imaging [29]
    • Genetic testing in consultation with a geneticist [6]
• Clinical features of a recognizable syndrome or genetic condition: Obtain genetic testing. [6]

Follow-up

• Ensure regular follow-up throughout infancy and childhood to track growth and development and monitor treatment adherence. [6][6]
• Adjust levothyroxine dose to keep TSH and FT₄ within the age-specific reference range. [6]
• Monitor thyroid function test results frequently after treatment adjustments. [6][29]
• Permanence of congenital hypothyroidism is confirmed by any of the following: [6]
  • Serum TSH rise by > 10 mIU/L after the first year of life
  • Thyroid dysgenesis on imaging
  • Trial discontinuation of levothyroxine at 3 years of age; elevated TSH or low free T₄ after 4 weeks

Etiology [32]

• The etiology of hypothyroidism is similar in adults and children with acquired hypothyroidism.
• Hashimoto thyroiditis is the most common cause in children in the US. [29]
• Risk factors for autoimmune thyroid disease in children include: [29]
  • Genetic syndromes (e.g., Down syndrome, Turner syndrome)
  • Other autoimmune conditions (e.g., diabetes mellitus, celiac disease, vitiligo)

Iodine deficiency is rare in the US but is the most common cause of acquired hypothyroidism in children worldwide. [29]

Clinical features [32][46]

In addition to general signs and symptoms of hypothyroidism, children with acquired hypothyroidism may have:

• Linear growth failure [32]
• Delayed puberty [29]

Goiter is the most common sign of acquired hypothyroidism in children. [29]

Diagnosis [32][46]

• The diagnostic workup for hypothyroidism is similar in adults and children.
• Similar to in adults, thyroid ultrasonography is not part of the primary workup but may be used to identify the underlying cause. [46]

The presence of antithyroid antibodies (e.g., TPOAb) in patients with subclinical hypothyroidism is a predictor of conversion to overt hypothyroidism. [29][32]

Management [32][46]

Management of hypothyroidism in adults and children is similar; consult pediatric endocrinology for treatment guidance. [32]

• Overt hypothyroidism
  • Initiate levothyroxine replacement to reverse symptoms and restore normal growth and development. [32]
  • Adjust levothyroxine dose as needed throughout childhood to maintain serum TSH and FT₄ levels within desired age-adjusted reference ranges. [32][46]
  • Perform regular developmental surveillance throughout childhood. [32]
• Subclinical hypothyroidism
  • TSH > 10 mIU/L: Consider levothyroxine if symptomatic or if risk factors for progression to overt hyperthyroidism are present (e.g., positive autoantibodies, goiter, other autoimmune diseases). [32][46]
  • TSH ≤ 10 mIU/L: Levothyroxine is not typically recommended. [32]